跳至主要内容
临床试验/KCT0001175
KCT0001175招募中未知

Efficacy of intramuscular diclofenac in the prevention of post-ERCP pancreatitis: a prospective, randomized, multicencer study

Yeongnam University Medical Center0 个研究点目标入组 1,544 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,544

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Subjects who agree to consent for the study
  • Intact major papilla

排除标准

  • 1) Unwillingness or inability to consent for the study
  • 2) Procedure performed on major papilla previously
  • 3) Standard contraindications to ERCP
  • 4) ERCP for biliary stent removal or exchange without anticipated pancreatogram
  • 5) Acute pancreatitis or acute exacerbation of chronic pancreatitis, elevatation of amylase or lipase level above three fold of upper normal limit within 72 hours
  • 6) Underlying severe heart, lung or endocrine disorder
  • 7) Severe abnormality in liver function
  • 8) Hematologic disorder
  • 9) Pregnancy or possibility of pregnancy
  • 10) Received Non-Steroidal Anti-Inflammatory Drugs in prior 7 days (aspirin 325 mg or less OK)
  • 11) Contraindication to Non-Steroidal Anti-Inflammatory Drugs (Renal failure (Cr > 1.4) or Active or recent gastrointestinal hemorrhage)
  • 12) Allergy / hypersensitivity to aspirin or Non-Steroidal Anti-Inflammatory Drugs

研究者

发起方
Yeongnam University Medical Center

相似试验